&w=3840&q=100)
Fortis Healthcare rallies 9%, nears record high; brokerages see more upside
The stock price of the hospital company is quoting at its highest level since January 8, 2025. It had hit a record high of ₹744 on December 30, 2024.
At 11:13 AM, Fortis Healthcare stock was trading 8 per cent higher at ₹724.20 on the BSE. In comparison, the BSE Sensex was down 0.88 per cent at 80,880.47. The average trading volumes on the counter jumped over fourfold. A combined 5.72 million equity shares representing 0.76 per cent of the total equity of Fortis Healthcare have changed hands on the NSE and BSE.
Fortis Healthcare Q4 & FY25 financial performance
Delhi-headquartered hospital chain Fortis Healthcare on Tuesday, May 20, 2025, reported a 7.4 per cent year-on-year (Y-o-Y) fall in consolidated net profit for the March quarter of financial year 2024–25 (Q4FY25) at ₹188.02 crore, down from ₹203.14 crore in the same period last year. The decline in net profit was attributed to a 13.6 per cent Y-o-Y rise in total expenses, which stood at ₹1,741.52 crore, up from ₹1,531.76 crore. The company also cited impairments on investments in an associate firm and assets in a subsidiary, according to its regulatory filing.
Revenue from operations rose to ₹2,007 crore in Q4FY25, marking a 12.4 per cent increase from ₹1,786 crore in Q4FY24. The increase in revenue was driven by strong performances in both the hospital and diagnostics businesses.
Consolidated earnings before interest, tax, depreciation, and amortisation (Ebitda) rose 14.3 per cent Y-o-Y to ₹435 crore, with the Ebitda margin at 21.7 per cent, up from 21.3 per cent in the year-ago period.
In FY25, the company's hospital business contributed 84 per cent to consolidated revenue compared to 82 per cent in FY24. Revenue from focus specialities comprising Oncology, Neurosciences, Cardiac Sciences, Gastroenterology, Orthopaedics and Renal Sciences grew 16 per cent Y-o-Y and contributed 62 per cent to overall hospital business revenues.
The management said the company has witnessed a steady improvement in the diagnostics business Ebitda margins (excluding one-offs) at 22.0 per cent in FY25 compared to 19.6 per cent in FY24. The new brand is being well accepted and gaining prominence, placing the business in a better position to drive business expansion and enhance performance metrics, the management said.
The company added 200 beds in FY25 and plans to add 993 beds in FY26, most of which are Brownfield projects.
Brokerages' view on Fortis Healthcare
JM Financial Institutional Securities - Due to ongoing efforts to improve the profitability of underperforming units, combined with significant Brownfield expansion, the company is poised to achieve over 15 per cent topline growth over the next three years, along with 200–300 bps margin expansion.
With improved profitability, the company is also expected to generate ₹3,980 crore in free cash flow over the next three years. At the Wednesday market price of ₹672, the stock is trading at 26.2x on a 1Y forward EV/Ebitda basis, which the brokerage firm believes is likely to expand in the coming years due to improving fundamentals. 'We value the company on a SOTP basis to arrive at a target price (TP) of ₹810. Maintain BUY on the stock,' the brokerage firm said in the Q4 result update.
Elara Capital - Strong growth continued in the hospitals segment. The management has guided for continued growth and a further 150- 200 bps margin expansion in FY26. Performance has started picking up in the diagnostics business as well – the management guided for double-digit growth in FY26, with margin recovering to ~23 per cent levels. 'We raise FY26E and FY27E core EPS estimates by 15-17 per cent, on strong guidance in both the business segments. So, we raise our TP to ₹749 from ₹686 – Retain Accumulate,' the brokerage firm said.
About Fortis Healthcare
Fortis Healthcare is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care speciality facilities. Currently, the company operates 27 healthcare facilities (including JVs and O&M facilities). The Company's network comprises approximately 4,750 operational beds (including O&M beds) and 404 diagnostics labs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
22 minutes ago
- Time of India
Aptus Value Housing Finance's profit rises 27.66% in Q1 FY26
NEW DELHI: Aptus Value Housing Finance India has reported a growth of 27.66 per cent in its net consolidated profit during the quarter ended June 30, 2025. Its profit after tax stood at ₹219.25 crore in Q1 FY26 as against ₹171.74 crore it registered in the corresponding quarter of the previous fiscal, the company said in a BSE filing. The company's net consolidated total income stood at ₹530.14 crore in Q1 FY26, a growth of 31.02 per cent from ₹404.62 crore it recorded in the similar quarter last year. P. Balaji , managing director of the company said, "Our customer base grew 20% year-on-year to 1.65 lakh customers, while our branch presence reached 301. On the profitability side, our spreads continue to hold up strongly at 8.7%. The opex continues to remain lower at 2.7%, leading to an operating PAT growth of 31% year-on-year to ₹296 crore. On the asset quality side, we saw slight increase in delinquency, driven by seasonality, leading to 19 bps sequential rise in our GNPAs to 1.49%. The credit cost was sequentially up by 8 bps but remain under our 45–50 bps credit cost guidance. We continued to lead in digital adoption, achieving >90% digital agreements and 94% digital collections. Our strong tech and analytics capabilities enabled safe, scalable operations across regions. With this momentum, we are confident that Aptus is well-positioned to reach an AUM of ₹25,000 crore by FY28-29." As on June 30, 2025, its net worth stood at ₹3,814.18 crore, debt-equity ratio was 1.31, total debts to total assets was 0.56, net profit margin was 42.30%, gross non-performing assets (NPA) was 1.34% and net NPA was 1%. The company's assets under management (AUM) grew by 24 per cent year-on-year to ₹11,267 crore while disbursements rose 15 per cent year-on-year to ₹775 crore.
Indian Express
22 minutes ago
- Indian Express
Google's proposed remedies in CCI antitrust case could bring more real-money gaming apps to Play Store
Google has proposed opening up Play Store in India to a larger number of real-money gaming (RMG) apps in response to an ongoing antitrust probe by the Competition Commission of India (CCI) related to the tech giant's alleged abuse of dominance in the RMG ecosystem. The broader Play Store access is part of a set of proposed remedies submitted by Google to CCI, according to a notice issued by the competition watchdog inviting public comments on the 'commitment offer'. The antitrust case stems from a complaint filed by Delhi-based online gaming platform Winzo in November last year. As part of its list of proposed fixes aimed at levelling the competitive field, Google said it would allow all real-money gaming apps to be distributed to users in India via Play Store, provided they are 'self-declared by developers as permissible online real-money games as per applicable laws/jurisprudence.' The company also indicated that it may update its advertising policies to allow ads for 'games of skill' in India as long as developers furnish proof showing that they are not 'games of chance' or gambling apps. The deadline for providing feedback on Google's proposed remedies is August 20, 2025. If approved by the CCI, these remedies would not only let developers of real-money gaming apps reach more Android users but also enable Google to earn more revenue from a wider pool of apps and ads for these apps shown on its platforms. As for the finer details of app fees and revenue-sharing from in-app purchases, Google still appears to be figuring it out. 'In parallel, Google is finalising its approach for an appropriate business model which considers developer commercial models in the RMG industry,' the company submitted to CCI. In regards to the CCI's decision to gather public feedback on its commitment proposal, Google told The Indian Express, 'We're pleased the CCI is market testing our proposed framework for real-money games (RMGs) in India. This development reflects our constructive discussions with the CCI and the Indian developer community along with our commitment to building a more open and safe ecosystem for RMG apps across Google Play and Google Ads.' 'We look forward to continuing to work with the CCI and the wider RMG ecosystem, and are confident our proposed framework will empower Indian developers, grow the digital economy, and prioritize user safety,' it added. The All India Gaming Federation (AIGF), an industry body which represents Mobile Premier League (MPL), Nazara, Gameskraft, and MyTeam11, among others, welcomed the Play Store changes proposed by Google. 'Over the past three years, we have actively engaged with all relevant stakeholders to help shape balanced and forward-looking policy outcomes for the sector. We're encouraged to see that this constructive engagement is bearing fruit, and believe this move will empower responsible operators, support innovation, and ensure a safer experience for Indian consumers,' Roland Landers, CEO of AIGF, said in a statement. As part of a pilot programme launched in 2022, Google only allowed apps involving daily fantasy sports (DFS) and rummy games to be hosted on the Play Store. While the pilot was supposed to last for a year, these two types of RMG apps remained on the app store. Now, Google has proposed to replace the pilot programme and allow the distribution of all RMGs, with certain conditions: – Developers will be required to self-declare that their apps are permissible online real-money games as per applicable Indian laws and jurisprudence. – Developers will need to submit proof that the app 'is in good standing' with a third-party body recognised by Google. These third-party bodies include industry associations such as AIGF as well as Federation of Indian Fantasy Sports (FIFS) and e-Gaming Federation (EGF). – Developers will also need to ensure that their apps are compliant with Google policies, including the Google Play-Developer Distribution Agreement (DDA) and Developer Program Policies (DPP), which it said will be updated to reflect these changes. Google said it would start allowing developers of compliant RMG apps on the Play Store within 120 days of the CCI accepting its remedies and issuing such an order. In response to concerns raised by CCI on Google permitting ads only from DFS and Rummy apps, the company has proposed that it will allow games of skill to be advertised in India provided: – The advertiser provides proof that it is in good standing with a Recognised Third Party. 'Recognised Third Parties will be required to meet objective criteria, and may include industry associations such as AIGF, EGF and FIFS,' it said. – The advertiser provides Third Party Certification that the game it intends to advertise is a permissible game of skill. – The advertiser complies with Google Ads Policies. If accepted by the CCI, Google said that the related ad policy changes will take effect within 150 days of the regulator's order.
Economic Times
22 minutes ago
- Economic Times
Market Wrap: Sensex ends 296 points lower, Nifty below 24,800 after brushing off Trump tariff salvo
Indian equities ended lower on Thursday but trimmed steeper early losses, as investors interpreted the U.S.'s proposed 25% tariff and unspecified penalties, set to take effect August 1, as a negotiating ploy rather than a definitive policy shift. ADVERTISEMENT The BSE Sensex shed 296.28 points, or 0.36%, to close at 81,185.58, while the NSE Nifty slipped 86.70 points, or 0.35%, to settle at 24,768.35. Both indexes had fallen nearly 0.9% earlier in the session. The benchmarks slid nearly 1% in early trade after U.S. President Donald Trump announced 25% tariffs on India, effective August 1, along with an unspecified penalty. He added that negotiations with India were ongoing. For the month, both the Sensex and Nifty dropped around 3%, with broader markets underperforming amid sustained foreign outflows and weak earnings from IT firms and major financials. Textile stocks were among the hardest hit by the tariff announcement, with Welspun Living, Vardhman Textiles, KPR Mills, and Gokaldas Exports falling between 3.2% and 5.1%. Adani Enterprises declined 4% after reporting a drop in first-quarter profit, hurt by subdued coal demand. ADVERTISEMENT The consumer goods sector rose 1.4%, the day's top gainer, led by Hindustan Unilever. Shares of the FMCG major climbed 3.4% as a revival in rural demand and a refreshed product portfolio lifted quarterly earnings. Mid-cap and small-cap stocks each lost about 1%. ADVERTISEMENT Following a turbulent start driven by fresh tariff threats, the Indian market started on a pessimistic note, said Vinod Nair, Head of Research, Geojit Investments, adding that the domestic market, however, attempted "a strong recovery but by the end of the day it closed with marginal losses, on a monthly expiry day." "Investors gravitated toward domestically oriented, non-discretionary players, especially FMCG, which offered attractive valuations, demand outlook and relative insulation from tariff risks. In contrast, oil & gas stocks were the worst hit due to US warnings over Indian energy imports. Overall, the market reflected a cautious yet selective approach. Market continues to hold high hopes for a more favorable tariff outcome in the near-term," said Nair. ADVERTISEMENT As the new series begins, the market is likely to consolidate, but global developments and corporate earnings will continue to drive volatility, said Ajit Mishra, SVP, Research, Religare Broking, adding that "we maintain our cautious stance and recommend a stock-specific approach, given the mixed trends across sectors. Traders should also avoid averaging down on loss-making positions." (You can now subscribe to our ETMarkets WhatsApp channel)
